Stock ARQT ARCUTIS BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Arcutis Biotherapeutics, Inc.

Equities

ARQT

US03969K1088

Real-time Estimate Cboe BZX
Other stock markets
 11:06:19 2024-06-03 am EDT 		5-day change 1st Jan Change
8.64 USD +3.35% Intraday chart for Arcutis Biotherapeutics, Inc. -3.43% +165.48%
May. 28 Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion MT
May. 15 Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating MT

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ARQT Stock
  4. News Arcutis Biotherapeutics, Inc.
  5. MarketScreener Strategies